IDEAYA Biosciences, Inc.
IDYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,099 | $2,047 | $753 | $833 |
| - Cash | $84 | $157 | $69 | $92 |
| + Debt | $19 | $3 | $3 | $5 |
| Enterprise Value | $2,034 | $1,892 | $688 | $747 |
| Revenue | $7 | $23 | $51 | $28 |
| % Growth | -70.1% | -54.1% | 82.3% | – |
| Gross Profit | $3 | $19 | $49 | $26 |
| % Margin | 45.2% | 82.9% | 95.9% | 93.8% |
| EBITDA | -$271 | -$109 | -$57 | -$48 |
| % Margin | -3,866.3% | -465.9% | -111% | -171.9% |
| Net Income | -$274 | -$113 | -$59 | -$50 |
| % Margin | -3,921.1% | -483% | -115.2% | -178.1% |
| EPS Diluted | -3.36 | -1.96 | -1.42 | -1.41 |
| % Growth | -71.4% | -38% | -0.7% | – |
| Operating Cash Flow | -$248 | -$115 | -$87 | -$56 |
| Capital Expenditures | -$4 | -$2 | -$3 | -$3 |
| Free Cash Flow | -$251 | -$118 | -$91 | -$58 |